托尔塞米德在治疗肺水腫中的作用
Agam Vora1, Amit Sharma2, Sivakadaksham3
1Chest Physician, Department of Medicine, Vora Clinic, Mumbai, Maharashtra, India, Corresponding Author.
托尔塞米德是心脏性肺水 (CPE) 的有效治疗方法,与罗塞米德相比,它具有优势. 需要进一步的研究来评估其在非心脏性肺水腫中的使用.
科学领域:
- 心脏病学 心脏病学
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 肺水腫涉及到膜空間中的液體,源自心臟病或非心臟病的起源.
- 心脏性肺 (CPE) 是充血性心力衰竭 (CHF) 的并发症.
- 循环利尿剂是与CHF相关的肺的标准治疗方法.
研究的目的:
- 为了比较torsemide和furosemide在治疗肺的疗效.
- 评估托塞米德作为心脏性肺水腫 (CPE) 的治疗选择.
主要方法:
- 该研究审查了torsemide和furosemide的药理特性和临床用途.
- 在CPE患者中评估了塞米德的静脉注射.
主要成果:
- 托塞米德和富罗塞米德都能降低肺所涉及的压力.
- 与furosemide相比,torsemide具有更高的生物可用性,吸收和疗效.
- 静脉输入的托塞米德在CPE患者中显示出有效性和耐受性.
结论:
- 托塞米德为治疗肺水提供了一个有希望的替代方案,特别是在CPE中.
- 需要进行额外的研究,以确定torsemide在非心脏性肺水腫中的有效性.
更多相关视频
08:44Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema
Published on: September 1, 2016
02:58Combination of High Ligation and Intraoperative Embolization using Polidocanol for Treatment of Varicoceles
Published on: December 22, 2023
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Heart Failure Drugs: Diuretics
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Thiazide-Class Diuretics
Disorder of Water Balance
Dehydration
Dehydration occurs when the body loses fluids (particularly water).
Causes:
The major causes of dehydration include excessive sweating, fever, vomiting, diarrhea, and diuresis.
Signs and Symptoms:
Symptoms primarily include intense...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
